The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.
- Published In:
- Drugs of today (Barcelona, Spain : 1998), 48 Suppl A, 3-24 (2012)
- Authors:
- Masliah, E, Díez-Tejedor, E
- Database ID:
- RPEP-02009
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02009APA
Masliah, E; Díez-Tejedor, E. (2012). The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.. Drugs of today (Barcelona, Spain : 1998), 48 Suppl A, 3-24. https://doi.org/10.1358/dot.2012.48(Suppl.A).1739716
MLA
Masliah, E, et al. "The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders.." Drugs of today (Barcelona, 2012. https://doi.org/10.1358/dot.2012.48(Suppl.A).1739716
RethinkPeptides
RethinkPeptides Research Database. "The pharmacology of neurotrophic treatment with Cerebrolysin..." RPEP-02009. Retrieved from https://rethinkpeptides.com/research/masliah-2012-the-pharmacology-of-neurotrophic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.